Thu. Sep 10, 2020 2:00 PM – 3:00 PM EDT Register Real-world data (RWD) is playing an increasing role in health care decisions, especially with autoimmune diseases where diagnosis can be difficult and there is no cure. Despite the promises of RWD to improve our understanding of the natural history of these diseases and to[…]
Collaboration enables otolaryngologists and researchers to leverage data for real-world evidence, outcomes, and personalized medicine programs BOSTON, May 13, 2020 — OM1, a real-world outcomes and technology company, today announced a strategic partnership with the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) connecting the Foundation’s Reg-entSM clinical data registry to OM1’s real-world data[…]
Tuesday, March 31 – 1:00 – 2:00 pm ET Register The promise of real-world data is driving increased requirements and use. But, what does high-quality RWD actually look like? How should life sciences companies access and use it most effectively? What are the implications when applying RWD to clinical trials, registries, and other evidence and[…]
Published February 28, 2020, HealthEconomics.com – written by Kathryn Starzyk, Senior Director, RWE, OM1 Technological innovations have fostered the age of big data in healthcare – and the huge populations amassed afford the ability to mine for key subpopulations — getting down to ever more precise groups of likely responders to therapy, high-risk patients and[…]
Wednesday, August 14, 2019 Being able to quickly and cost-effectively collect, analyze, and share real-world evidence on a treatment is critical to improving outcomes in rheumatology conditions. Fortunately, advances in data linkage and processing capabilities are enabling greater access to patient journeys via deep, linked clinical data. At the same time, new tools are empowering[…]
